Int. J. Mol. Sci. 2014, 15, 10296-10333; doi:10.3390/ijms150610296 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Erythropoietin Action in Stress Response, Tissue Maintenance and Metabolism Yuanyuan Zhang 1, Li Wang 2, Soumyadeep Dey 1, Mawadda Alnaeeli 3,4, Sukanya Suresh 1, Heather Rogers 1, Ruifeng Teng 5 and Constance Tom Noguchi 1,* 1 Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA; E-Mails:
[email protected] (Y.Z.);
[email protected] (S.D.);
[email protected] (S.S.);
[email protected] (H.R.) 2 Faculty of Health Sciences, University of Macau, Macau SAR, China; E-Mail:
[email protected] 3 Department of Biological Sciences, Ohio University, Zanesville, OH 43701, USA; E-Mail:
[email protected] 4 Diabetes Institute, Ohio University, Athens, OH 45701, USA 5 Mouse Metabolism Core Laboratory, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA; E-Mail:
[email protected] * Author to whom correspondence should be addressed; E-Mail:
[email protected]; Tel.: +1-301-496-1163; Fax: +1-301-402-0101. Received: 20 February 2014; in revised form: 23 May 2014 / Accepted: 28 May 2014 / Published: 10 June 2014 Abstract: Erythropoietin (EPO) regulation of red blood cell production and its induction at reduced oxygen tension provides for the important erythropoietic response to ischemic stress. The cloning and production of recombinant human EPO has led to its clinical use in patients with anemia for two and half decades and has facilitated studies of EPO action.